ScreenerHero

TLX Telix Pharmaceuticals Limited

ASX · AU · Healthcare · Biotechnology · telixpharma.com
—Mkt Cap: —P/E: —

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segment…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.87BUSDP/E 29.6
MRNA
Moderna, Inc.
$94.42BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$81.99BUSDP/E 19.1
ARGX
argenx SE
$53.47BUSDP/E 32.5
ARGX
argenx SE
$53.22BUSDP/E 31.6
UCB
UCB SA
$44.02BUSDP/E 17.8
ONC
BeOne Medicines AG
$42.56BUSDP/E 66.4
RVMD
Revolution Medicines, Inc.
$40.57BUSD
RPRX
Royalty Pharma plc
$34.45BUSDP/E 30.4
ALNY
Alnylam Pharmaceuticals, Inc.
$31.32BUSDP/E 39.3
ROIV
Roivant Sciences Ltd.
$24.59BUSD
GMAB
Genmab A/S
$23.32BUSDP/E 31.7
GMAB
Genmab A/S
$23.26BUSDP/E 29.8
INCY
Incyte Corporation
$22.96BUSDP/E 14.0
BNTX
BioNTech SE
$22.66BUSD
INSM
Insmed Incorporated
$21.67BUSD
EXEL
Exelixis, Inc.
$15.57BUSDP/E 19.3
ASND
Ascendis Pharma A/S
$14.91BUSDP/E 17.4
JAZZ
Jazz Pharmaceuticals plc
$13.92BUSDP/E 14.7
HALO
Halozyme Therapeutics, Inc.
$13.79BUSDP/E 33.4

Key Statistics

Company
Market Cap—
Enterprise Value3.77B USD
Revenue (TTM)615.61M USD
Gross Profit294.70M USD
Net Income (TTM)-4.92M USD
Revenue/Share2.61 AUD
Last Price—
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.1K
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU000000TLX2
Valuation
P/E (Trailing)—
P/E (Forward)-814.77
PEG—
EV/EBITDA78.10
EV/Revenue6.12
P/S5.70
P/B7.29
EPS (TTM)0.14
EPS (Forward)-0.02
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin53.05%
Oper. Margin9.71%
EBITDA Margin7.84%
Profit Margin-0.89%
ROE-1.72%
ROA-0.61%
Growth
Revenue Growth22.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.30M USD
CapEx (TTM)30.25M USD
FCF Margin-7.03%
FCF Yield—
Net Debt226.64M USD
Net Debt/EBITDA4.70
Balance Sheet
Debt/Equity1.12
Current Ratio2.01
Quick Ratio1.74
Book Value/Sh2.06 AUD
Cash/Share0.74 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)24.39 AUD
Target Range19.00 AUD – 32.00 AUD
# Analysts11
Ownership
Shares Out.338.78M
Float273.61M
Insiders15.81%
Institutions34.17%
Technical
SMA 5016.20 AUD
SMA 20013.90 AUD
Beta0.56
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)1.51M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—